Document Detail

Effects of AV3V lesion on pilocarpine-induced pressor response and salivary gland vasodilation.
MedLine Citation:
PMID:  16054600     Owner:  NLM     Status:  MEDLINE    
The cholinergic agonist pilocarpine injected intraperitoneally (ip) increases mean arterial pressure (MAP) and superior mesenteric (SM) vascular resistance and reduces submandibular/sublingual gland (SSG) vascular resistance. In the present study, we investigated the effects of electrolytic lesions of the anteroventral third ventricle (AV3V) region on the changes in MAP, SM, and SSG vascular resistances induced by ip pilocarpine. Male Holtzman rats anesthetized with urethane (1.0 g/kg) and chloralose (60 mg/kg) were submitted to sham or electrolytic AV3V lesions and had pulsed Doppler flow probes implanted around the arteries. Contrary to sham rats, in 1-h and 2-day AV3V-lesioned rats, pilocarpine (4 micromol/kg) ip decreased MAP (-41 +/- 4 and -26 +/- 4 mm Hg, respectively, vs. sham: 19 +/- 4 mm Hg) and SM (-48 +/- 11 and -45 +/- 10%, respectively, vs. sham: 41 +/- 10%) and hindlimb vascular resistances (-65 +/- 32 and -113 +/- 29%, respectively, vs. sham: 19 +/- 29%). In 7-day AV3V-lesioned rats, pilocarpine produced no changes on MAP and SM and hindlimb vascular resistances. Similar to sham rats, pilocarpine reduced SSG vascular resistance 1 h after AV3V lesions (-46 +/- 6%, vs. sham: -40 +/- 6%), but it produced no effect 2 days after AV3V lesions and increased SSG vascular resistance (37 +/- 6%) in 7-day AV3V-lesioned rats. The responses to ip pilocarpine were similar in 15-day sham and AV3V-lesioned rats. The cholinergic antagonist atropine methyl bromide (10 nmol) iv slightly increased the pressor response to ip pilocarpine in sham rats and abolished for 40 min the fall in MAP induced by ip pilocarpine in 1-h AV3V-lesioned rats. The results suggest that central mechanisms dependent on the AV3V region are involved in the pressor responses to ip pilocarpine. Although it was impaired 2 and 7 days after AV3V lesions, pilocarpine-induced salivary gland vasodilation was not altered 1 h after AV3V lesions which suggests that this vasodilation is not directly dependent on the AV3V region.
Ana Carolina Thomaz Takakura; Thiago Santos Moreira; Laurival Antonio De Luca; Antonio Renzi; José Vanderlei Menani; Eduardo Colombari
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Brain research     Volume:  1055     ISSN:  0006-8993     ISO Abbreviation:  Brain Res.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-09-05     Completed Date:  2006-01-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0045503     Medline TA:  Brain Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  111-21     Citation Subset:  IM    
Department of Physiology, Universidade Federal de São Paulo-Escola Paulista de Medicina, 04023-060, São Paulo, SP, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Atropine / pharmacology
Blood Pressure / drug effects*
Drug Interactions
Electrolysis / adverse effects
Heart Rate / drug effects
Injections, Intraventricular
Laser-Doppler Flowmetry / methods
Muscarinic Agonists / pharmacology*
Muscarinic Antagonists / pharmacology
Pilocarpine / pharmacology*
Salivary Glands / drug effects*,  physiology
Third Ventricle / drug effects*,  injuries
Time Factors
Vasodilation / drug effects*
Reg. No./Substance:
0/Muscarinic Agonists; 0/Muscarinic Antagonists; 51-55-8/Atropine; 92-13-7/Pilocarpine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exercise increased BDNF and trkB in the contralateral hemisphere of the ischemic rat brain.
Next Document:  Effect of 5-HT depletion on cardiovascular vagal reflex sensitivity in awake and anesthetized rats.